Adaptive Biotechnologies Corporation (ADPT) vs Veracyte, Inc. (VCYT)
- Adaptive Biotechnologies Corporation ADPT 24.02 −6.10%
- Veracyte, Inc. VCYT 43.12 −2.86%
Adaptive Biotechnologies Corporation and Veracyte, Inc. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation is the larger, with a market value of $4.1B against $3.6B — 1.1× the size. Adaptive Biotechnologies Corporation has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 29.9×. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 50.1% against 17.3%. Veracyte, Inc. has the higher net margin (20.4% vs −20.7%) and the higher return on invested capital (7.32% vs −16.6%). Across the 18 metrics below, Veracyte, Inc. leads on 16 and Adaptive Biotechnologies Corporation on 2.
Valuation
Profitability
| Metric | ADPT | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 75.57% | 71.71% | 50.89% |
| Operating margin | (12.16%) | 18.82% | (8.57%) |
| Net margin | (20.73%) | 20.37% | (6.37%) |
| Free cash flow margin | (7.80%) | 29.54% | 0.00% |
| Return on equity | (38.68%) | 8.77% | (2.92%) |
| Return on assets | (11.23%) | 8.09% | (6.71%) |
| Return on invested capital | (16.57%) | 7.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack